Trending Stocks : Ariad Pharmaceuticals (NASDAQ:ARIA), Checkpoint (NYSE:CKP), Computer Sciences (NYSE:CSC), Seattle Genetics Inc. (NASDAQ:SGEN), Infoblox Inc. (NYSE:BLOX)

US specialty pharma firm Ariad Pharmaceuticals (NASDAQ:ARIA) has granted Israel’s Medison Pharma exclusive rights to commercialize Iclusig (ponatinib) in Israel for patients with Philadelphia-positive (Ph+) leukemias. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -12.09%. On last trading day company shares ended up $5.38. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -12.94%.

Checkpoint Systems, Inc. (NYSE:CKP) today reported financial results for the second quarter ended June 29, 2014. Net revenues from continuing operations in the second quarter of 2014 decreased 0.8%, to $170.9 million from $172.3 million in the second quarter of 2013. Foreign currency translation effects resulted in a $1.0 million or 0.6% increase in net revenues. During the quarter, gross profit margins were 42.4% compared with 40.6% in the 2013 second quarter. Checkpoint Systems Inc. (NYSE:CKP) shares advanced 5.16% in last trading session and ended the day at $14.05. CKP Gross Margin is 40.40% and its return on assets is -1.50%. Checkpoint Systems Inc. (NYSE:CKP) quarterly performance is 9.68%.

Computer Sciences Corporation (NYSE:CSC) is set to report first-quarter 2015 results on Aug 7. Last quarter, the company posted a positive earnings surprise of 5.8%. Moreover, it is worth noting that Computer Sciences has outperformed the Zacks Consensus Estimate in all the four preceding quarters with an average positive surprise of 19.9%. On 06 August, Computer Sciences Corporation (NYSE:CSC) shares moved down -0.42% and was closed at $62.10. CSC EPS growth in last 5 year was -11.30%. Computer Sciences Corporation (NYSE:CSC) year to date (YTD) performance is 11.89%.

This week, Seattle Genetics, Inc.’s (NASDAQ:SGEN) ratings are up from a C last week to a B. Seattle Genetics is a clinical-stage biotechnology company that is focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. Seattle Genetics Inc. (NASDAQ:SGEN) ended the last trading day at $38.75. Company weekly volatility is calculated as 5.68%and price to cash ratio as 13.43. Seattle Genetics Inc. (NASDAQ:SGEN) showed a weekly performance of 7.97%.

Infoblox Inc. (NYSE:BLOX), the network control company, today announced that its Infoblox Automation Solutions Architect (IASA) program has trained and certified more than 900 pre-sales engineers worldwide, less than two and a half years after the program’s launch. Infoblox Inc. (NYSE:BLOX) shares moved down -1.05% in last trading session and ended the day on $12.20. BLOX Gross Margin is 77.90% and its return on assets is -3.70%. Infoblox Inc. (NYSE:BLOX) quarterly performance is -31.46%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone